| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.21 | 2e-05 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | -0.15 | 5e-05 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.14 | 0.001 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | -0.12 | 0.002 |